{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:24:51Z","timestamp":1787163891386,"version":"build-2736575974"},"reference-count":76,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Cell Commun. Signal."],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s12079-023-00750-1","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T09:02:53Z","timestamp":1682586173000},"page":"549-561","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Ephrin\u2013Eph receptor tyrosine kinases for potential therapeutics against hepatic pathologies"],"prefix":"10.1002","volume":"17","author":[{"given":"Sowmya","family":"Mekala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prachi","family":"Dugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7510-1805","authenticated-orcid":false,"given":"Amitava","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,4,27]]},"reference":[{"key":"750_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12079-012-0180-4","volume":"7","author":"T Abd El Kader","year":"2013","unstructured":"Abd El Kader T, Kubota S, Janune D, Nishida T, Hattori T, Aoyama E, Perbal B, Kuboki T, Takigawa M (2013) Anti-fibrotic effect of CCN3 accompanied by altered gene expression profile of the CCN family. J Cell Commun Signal 7:11\u201318. https:\/\/doi.org\/10.1007\/s12079-012-0180-4","journal-title":"J Cell Commun Signal"},{"key":"750_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/labinvest.2010.166","volume":"9","author":"A Alisi","year":"2011","unstructured":"Alisi A, Da Sacco L, Bruscalupi G, Piemonte F, Panera N, De Vito R, Leoni S, Bottazzo GF, Masotti A, Nobili V (2011) Mirnome analysis reveals novel molecular determinants in the pathogenesis of the diet-induced nonalcoholic fatty liver disease. Lab Invest 9:283\u2013293. https:\/\/doi.org\/10.1038\/labinvest.2010.166","journal-title":"Lab Invest"},{"key":"750_CR3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/molbev\/msz222","volume":"37","author":"A Arcas","year":"2020","unstructured":"Arcas A, Wilkinson DG, Nieto MA (2020) The evolutionary history of Ephs and Ephrins: toward multicellular organisms. Mol Biol Evol 37:379\u2013394. https:\/\/doi.org\/10.1093\/molbev\/msz222","journal-title":"Mol Biol Evol"},{"key":"750_CR4","doi-asserted-by":"publisher","first-page":"12756","DOI":"10.1038\/s41598-018-31190-2","volume":"8","author":"A Arthur","year":"2018","unstructured":"Arthur A, Nguyen TM, Paton S, Klisuric A, Zannettino ACW, Gronthos S (2018) The osteoprogenitor-specific loss of ephrinB1 results in an osteoporotic phenotype affecting the balance between bone formation and resorption. Sci Rep 8:12756. https:\/\/doi.org\/10.1038\/s41598-018-31190-2","journal-title":"Sci Rep"},{"key":"750_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1158\/1078-0432.CCR-11-0111","volume":"18","author":"F Azab","year":"2013","unstructured":"Azab F, Azab AK, Maiso P, Calimeri T, Flores L, Liu Y, Quang P, Roccaro AM, Sacco A, Ngo HT, Zhang Y (2013) Eph-B2\/Ephrin-B2 interaction plays a major role in the adhesion and proliferation of Waldenstrom\u2019s macroglobulinemia. Clin Cancer Res 18:91\u2013105. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-0111","journal-title":"Clin Cancer Res"},{"key":"750_CR6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.4149\/neo_2009_04_331","volume":"56","author":"HJ Bae","year":"2009","unstructured":"Bae HJ, Song JH, Noh JH, Kim JK, Jung KH, Eun JW, Xie HJ, Ryu JC, Ahn YM, Kim SY, Lee SH (2009) Low-frequency mutation of the Ephrin receptor A3 gene in hepatocellular carcinoma. Neoplasma 56:331\u2013334. https:\/\/doi.org\/10.4149\/neo_2009_04_331","journal-title":"Neoplasma"},{"key":"750_CR7","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/368558a0","volume":"368","author":"TD Bartley","year":"1994","unstructured":"Bartley TD, Hunt RW, Welcher AA, Boyle WJ, Parker VP, Lindberg RA, Lu HS, Colombero AM, Elliott RL, Guthrie BA, Holst PL (1994) B61 is a ligand for the Eck receptor protein-tyrosine kinase. Nature 368:558\u2013560. https:\/\/doi.org\/10.1038\/368558a0","journal-title":"Nature"},{"key":"750_CR8","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/nature03626","volume":"435","author":"E Batlle","year":"2005","unstructured":"Batlle E, Bacani J, Begthel H, Jonkheer S, Gregorieff A, van de Born M, Malats N, Sancho E, Boon E, Pawson T, Gallinger S, Pals S, Clevers H (2005) EphB receptor activity suppresses colorectal cancer progression. Nature 435:1126\u20131130. https:\/\/doi.org\/10.1038\/nature03626","journal-title":"Nature"},{"key":"750_CR9","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.1002\/j.1460-2075.1994.tb06685.x","volume":"13","author":"MP Beckmann","year":"1994","unstructured":"Beckmann MP, Cerretti DP, Baum P, Vanden Bos T, James L, Farrah T, Kozlovsky C, Hollingsworth T, Shilling H, Maraskovsky E (1994) Molecular characterization of a family of ligands for Eph-related tyrosine kinase receptors. EMBO J 13:3757\u20133762. https:\/\/doi.org\/10.1002\/j.1460-2075.1994.tb06685.x","journal-title":"EMBO J"},{"key":"750_CR10","doi-asserted-by":"publisher","first-page":"715","DOI":"10.4254\/wjh.v9.i16.715","volume":"9","author":"M Benedict","year":"2017","unstructured":"Benedict M, Zhang X (2017) Non-alcoholic fatty liver disease: an expanded review. World J Hepatol 9:715\u2013732. https:\/\/doi.org\/10.4254\/wjh.v9.i16.715","journal-title":"World J Hepatol"},{"key":"750_CR11","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1242\/jcs.061903","volume":"123","author":"ML Bochenek","year":"2010","unstructured":"Bochenek ML, Dickinson S, Astin JW, Adams RH, Nobes CD (2010) Ephrin-B2 regulates endothelial cell morphology and motility independently of Eph-receptor binding. J Cell Sci 123:1235\u20131246. https:\/\/doi.org\/10.1242\/jcs.061903","journal-title":"J Cell Sci"},{"key":"750_CR12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3892\/or_00000670","volume":"23","author":"G Chen","year":"2010","unstructured":"Chen G, Wang Y, Zhou M, Shi H, Yu Z, Zhu Y, Yu F (2010) EphA1 receptor silencing by small interfering RNA has antiangiogenic and antitumor efficacy in hepatocellular carcinoma. Oncol Rep 23:563\u2013570. https:\/\/doi.org\/10.3892\/or_00000670","journal-title":"Oncol Rep"},{"key":"750_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2020.00007","volume":"12","author":"Q Chen","year":"2020","unstructured":"Chen Q, Song H, Liu C, Xu J, Wei C, Wang W, Han F (2020a) The interaction of EphA4 With PDGFR \u03b2 regulates proliferation and neuronal differentiation of neural progenitor cells in vitro and promotes neurogenesis in vivo. Front Aging Neurosci 12:1\u201314. https:\/\/doi.org\/10.3389\/fnagi.2020.00007","journal-title":"Front Aging Neurosci"},{"key":"750_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-020-2613-y","volume":"11","author":"X Chen","year":"2020","unstructured":"Chen X, Zhang D, Wang Y, Chen K, Zhao L, Xu Y, Jiang H, Wang S (2020b) Synergistic antifibrotic effects of miR-451 with miR-185 partly by co-targeting EphB2 on hepatic stellate cells. Cell Death Dis 11:1\u20133. https:\/\/doi.org\/10.1038\/s41419-020-2613-y","journal-title":"Cell Death Dis"},{"key":"750_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0092-8674(94)90408-1","volume":"79","author":"HJ Cheng","year":"1994","unstructured":"Cheng HJ, Flanagan JG (1994) Identification and cloning of ELF-1, a developmentally expressed ligand for the Mek4 and Sek receptor tyrosine kinases. Cell 79:157\u2013168. https:\/\/doi.org\/10.1016\/0092-8674(94)90408-1","journal-title":"Cell"},{"key":"750_CR16","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1002\/hep.26253","volume":"1","author":"XD Cui","year":"2012","unstructured":"Cui XD, Lee MJ, Kim JH, Hao PP, Liu L, Yu GR, Kim DG (2012) Activation of mammalian target of rapamycin complex 1 (mTORC1) and Raf\/Pyk2 by growth factor-mediated Eph receptor 2 (EphA2) is required for cholangiocarcinoma growth and metastasis. Hepatol 1:2248\u20132260. https:\/\/doi.org\/10.1002\/hep.26253","journal-title":"Hepatol"},{"key":"750_CR17","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/s0092-8674(00)00197-5","volume":"103","author":"MB Dalva","year":"2000","unstructured":"Dalva MB, Takasu MA, Lin MZ, Shamah SM, Hu L, Gale NW, Greenberg ME (2000) EphB receptors interact with NMDA receptors and regulate excitatory synapse formation. Cell 103:945\u2013956. https:\/\/doi.org\/10.1016\/s0092-8674(00)00197-5","journal-title":"Cell"},{"key":"750_CR18","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1152\/ajpgi.00510.2009","volume":"298","author":"A Das","year":"2010","unstructured":"Das A, Shergill U, Thakur L, Sinha S, Urrutia R, Mukhopadhyay D, Shah VH (2010) Ephrin B2\/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitment. Am J Physiol Gastrointest Liver Physiol 298:908\u2013915. https:\/\/doi.org\/10.1152\/ajpgi.00510.2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"4","key":"750_CR19","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1053\/j.gastro.2011.12.052","volume":"142","author":"MT Dill","year":"2012","unstructured":"Dill MT, Rothweiler S, Djonov V, Hlushchuk R, Tornillo L, Terracciano L, Meili-Butz S, Radtke F, Heim MH, Semela D (2012) Disruption of Notch1 induces vascular remodeling, intussusceptive angiogenesis, and angiosarcomas in livers of mice. Gastroenterol 142(4):967-977.e2. https:\/\/doi.org\/10.1053\/j.gastro.2011.12.052","journal-title":"Gastroenterol"},{"issue":"69","key":"750_CR20","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/s0959-8049(16)32623-5","volume":"1","author":"A El-Khoueiry","year":"2016","unstructured":"El-Khoueiry A, Gitlitz B, Cole S, Tsao-Wei D, Goldkorn A, Quinn D, Lenz HJ, Nieva J, Dorff T, Oswald M, Berg J (2016) A first-in-human phase I study of sEphB4-HSA in patients with advanced solid tumors with expansion at the maximum tolerated dose (MTD) or recommended phase II dose (RP2D). Eur J Cancer 1(69):S11. https:\/\/doi.org\/10.1016\/s0959-8049(16)32623-5","journal-title":"Eur J Cancer"},{"key":"750_CR21","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1177\/030089161309900608","volume":"99","author":"M Fan","year":"2013","unstructured":"Fan M, Liu Y, Xia F, Wang Z, Huang Y, Li J, Wang Z, Li X (2013) Increased expression of EphA2 and E\u2013N cadherin switch in primary hepatocellular carcinoma. Tumori 99:689\u2013696. https:\/\/doi.org\/10.1177\/030089161309900608","journal-title":"Tumori"},{"key":"750_CR22","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.3892\/ijmm.2018.3780","volume":"42","author":"YW Ge","year":"2018","unstructured":"Ge YW, Liu ZQ, Sun ZY, Yu DG, Feng K, Zhu ZA, Mao YQ (2018) Titanium particle-mediated osteoclastogenesis may be attenuated via bidirectional ephrin-B2\/Eph-B4 signaling in vitro. Int J Mol Med 42:2031\u20132041. https:\/\/doi.org\/10.3892\/ijmm.2018.3780","journal-title":"Int J Mol Med"},{"key":"750_CR23","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1210\/js.2018-00122","volume":"5","author":"GS Gerhard","year":"2018","unstructured":"Gerhard GS, Legendre C, Still CD, Chu X, Petrick A, DiStefano JK (2018) Transcriptomic profiling of obesity-related nonalcoholic steatohepatitis reveals a core set of fibrosis-specific genes. J Endocr Soc 5:710\u2013726. https:\/\/doi.org\/10.1210\/js.2018-00122","journal-title":"J Endocr Soc"},{"key":"750_CR24","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s12253-009-9221-6","volume":"16","author":"C Giaginis","year":"2010","unstructured":"Giaginis C, Tsourouflis G, Zizi-Serbetzoglou A, Kouraklis G, Chatzopoulou E, Dimakopoulou K, Theocharis SE (2010) Clinical significance of ephrin (Eph)-A1, -A2, -a4, -a5 and -a7 receptors in pancreatic ductal adenocarcinoma. Pathol Oncol Res 16:267\u2013276. https:\/\/doi.org\/10.1007\/s12253-009-9221-6","journal-title":"Pathol Oncol Res"},{"key":"750_CR25","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1373\/clinchem.2003.026849","volume":"50","author":"C Hafner","year":"2004","unstructured":"Hafner C, Schmitz G, Meyer S, Bataille F, Hau P, Langmann T, Dietmaier W, Landthaler M, Vogt T (2004) Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers. Clin Chem 50:490\u2013499. https:\/\/doi.org\/10.1373\/clinchem.2003.026849","journal-title":"Clin Chem"},{"key":"750_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/s0166-2236(02)00005-x","volume":"26","author":"JP Himanen","year":"2003","unstructured":"Himanen JP, Nikolov DB (2003) Eph signaling: a structural view. Trends Neurosci 26:46\u201351. https:\/\/doi.org\/10.1016\/s0166-2236(02)00005-x","journal-title":"Trends Neurosci"},{"key":"750_CR27","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nn1237","volume":"7","author":"J Himanen","year":"2004","unstructured":"Himanen J, Chumley MJ, Lackmann M, Li C, Barton WA, Jeffrey PD, Vearing C, Geleick D, Feldheim DA, Boyd AW, Henkemeyer M (2004) Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling. Nat Neurosci 7:501\u2013509. https:\/\/doi.org\/10.1038\/nn1237","journal-title":"Nat Neurosci"},{"key":"750_CR28","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1126\/science.2825356","volume":"238","author":"H Hirai","year":"1987","unstructured":"Hirai H, Maru Y, Hagiwara K, Nishida J, Takaku F (1987) A novel putative tyrosine kinase receptor encoded by the Eph gene. Science 238:1717\u20131720. https:\/\/doi.org\/10.1126\/science.2825356","journal-title":"Science"},{"key":"750_CR29","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.2741\/4067","volume":"17","author":"G Huang","year":"2012","unstructured":"Huang G, Brigstock DR (2012) Regulation of hepatic stellate cells by connective tissue growth factor. Front Biosci (landmark Ed) 17:2495\u20132507. https:\/\/doi.org\/10.2741\/4067","journal-title":"Front Biosci (landmark Ed)"},{"key":"750_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jhep.2022.02.018","volume":"8278","author":"A Husain","year":"2022","unstructured":"Husain A, Chiu YT, Sze KM, Ho DW, Tsui YM, Suarez EM, Zhang VX, Chan LK, Lee E, Lee JM, Cheung TT (2022) Ephrin-A3\/EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinoma. J Hepatol 8278:125\u2013128. https:\/\/doi.org\/10.1016\/j.jhep.2022.02.018","journal-title":"J Hepatol"},{"key":"750_CR31","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1136\/gutjnl-2017-315691","volume":"67","author":"SH Ibrahim","year":"2018","unstructured":"Ibrahim SH, Hirsova P, Gores GJ (2018) Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation. Gut 67:963\u2013972. https:\/\/doi.org\/10.1136\/gutjnl-2017-315691","journal-title":"Gut"},{"key":"750_CR32","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1136\/gut.2004.049486","volume":"54","author":"H Iida","year":"2005","unstructured":"Iida H, Honda M, Kawai HF, Yamashita T, Shirota Y, Wang BC, Miao H, Kaneko S (2005) Ephrin-A1 expression contributes to the malignant characteristics of \u03b1-fetoprotein producing hepatocellular carcinoma. Gut 54:843\u2013851. https:\/\/doi.org\/10.1136\/gut.2004.049486","journal-title":"Gut"},{"key":"750_CR33","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1007\/s00125-013-2877-1","volume":"56","author":"R Jain","year":"2013","unstructured":"Jain R, Jain D, Liu Q, Bartosinska B, Wang J, Schumann D, Kauschke SG, Eickelmann P, Piemonte L, Gray NS, Lammert E (2013) Pharmacological inhibition of Eph receptors enhances glucose-stimulated insulin secretion from mouse and human pancreatic islets. Diabetologia 56:1350\u20131355. https:\/\/doi.org\/10.1007\/s00125-013-2877-1","journal-title":"Diabetologia"},{"key":"750_CR34","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.18632\/oncotarget.6209","volume":"7","author":"Q Jia","year":"2016","unstructured":"Jia Q, Dong Q, Qin L (2016) CCN: core regulatory proteins in the microenvironment that affect the metastasis of hepatocellular carcinoma. Oncotarget 7:1203\u20131214. https:\/\/doi.org\/10.18632\/oncotarget.6209","journal-title":"Oncotarget"},{"key":"750_CR35","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.neuron.2011.05.031","volume":"71","author":"T Kao","year":"2011","unstructured":"Kao T, Kania A (2011) Ephrin-mediated cis -attenuation of Eph receptor signaling is essential for spinal motor axon guidance. Neuron 71:76\u201391. https:\/\/doi.org\/10.1016\/j.neuron.2011.05.031","journal-title":"Neuron"},{"key":"750_CR36","doi-asserted-by":"publisher","first-page":"10031","DOI":"10.1007\/s13277-014-2295-0","volume":"35","author":"W Khansaard","year":"2014","unstructured":"Khansaard W, Techasen A, Namwat N, Yongvanit P, Khuntikeo N, Puapairoj A, Loilome W (2014) Increased EphB2 expression predicts cholangiocarcinoma metastasis. Tumor Biol 35:10031\u201310041. https:\/\/doi.org\/10.1007\/s13277-014-2295-0","journal-title":"Tumor Biol"},{"key":"750_CR37","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1002\/hep4.2057","volume":"6","author":"KH Kim","year":"2022","unstructured":"Kim KH, Cheng N, Lau LF (2022) Cellular communication network factor 1-stimulated liver macrophage efferocytosis drives hepatic stellate cell activation and liver fibrosis. Hepatol Commun 6:2798\u20132811. https:\/\/doi.org\/10.1002\/hep4.2057","journal-title":"Hepatol Commun"},{"key":"750_CR38","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nrm856","volume":"3","author":"K Kullander","year":"2002","unstructured":"Kullander K, Klein R (2002) Mechanisms and functions of Eph and ephrin signaling. Nat Commun Mol Cell Biol 3:475\u2013486. https:\/\/doi.org\/10.1038\/nrm856","journal-title":"Nat Commun Mol Cell Biol"},{"key":"750_CR39","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1158\/0008-5472.can-21-0184","volume":"81","author":"HW Leung","year":"2021","unstructured":"Leung HW, Leung CON, Lau EY et al (2021) EPHB2 activates \u03b2-catenin to enhance cancer stem cell properties and drive sorafenib resistance in hepatocellular carcinoma. Cancer Res 81:3229\u20133240. https:\/\/doi.org\/10.1158\/0008-5472.can-21-0184","journal-title":"Cancer Res"},{"key":"750_CR40","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.3390\/ijms24043415","volume":"24","author":"R Li","year":"2023","unstructured":"Li R, Zhang D, Han Y, Chen K, Guo W, Chen Y, Wang S (2023) Neddylation of EphB1 regulates its activity and associates with liver fibrosis. Int J Mol Sci 24:3415. https:\/\/doi.org\/10.3390\/ijms24043415","journal-title":"Int J Mol Sci"},{"key":"750_CR41","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.neuron.2008.07.032","volume":"59","author":"YS Lim","year":"2008","unstructured":"Lim YS, McLaughlin T, Sung TC, Santiago A, Lee KF, O\u2019Leary DD (2008) p75NTR mediates ephrin-A reverse signaling required for axon repulsion and mapping. Neuron 59:746\u2013758. https:\/\/doi.org\/10.1016\/j.neuron.2008.07.032","journal-title":"Neuron"},{"key":"750_CR42","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3892\/etm.2011.215","volume":"2","author":"S Liu","year":"2011","unstructured":"Liu S, Gong J, Morishita A, Nomura T, Miyoshi H, Tani J, Kato K, Yoneyama H, Deguchi A, Mori H, Mimura S (2011) Use of protein array technology to investigate receptor tyrosine kinases activated in hepatocellular carcinoma. Exp Therap Med 2:399\u2013403. https:\/\/doi.org\/10.3892\/etm.2011.215","journal-title":"Exp Therap Med"},{"key":"750_CR43","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.3892\/ol.2014.2011","volume":"7","author":"C Liu","year":"2014","unstructured":"Liu C, Huang H, Wang C, Kong Y, Zhang H (2014) Involvement of ephrin receptor A4 in pancreatic cancer cell motility and invasion. Oncol Lett 7:2165\u20132169. https:\/\/doi.org\/10.3892\/ol.2014.2011","journal-title":"Oncol Lett"},{"key":"750_CR44","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3348\/kjr.2016.17.3.396","volume":"17","author":"J Liu","year":"2016","unstructured":"Liu J, Ji Y, Ai H, Ning B, Zhao J, Zhang Y, Dun G (2016) Liver shear-wave velocity and serum fibrosis markers to diagnose hepatic fibrosis in patients with chronic viral hepatitis B. Kor J Radiol 17:396\u2013404. https:\/\/doi.org\/10.3348\/kjr.2016.17.3.396","journal-title":"Kor J Radiol"},{"key":"750_CR45","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/s0968-0004(02)02179-5","volume":"27","author":"G Manning","year":"2002","unstructured":"Manning G, Plowman GD, Hunter T, Sudarsanam S (2002) Evolution of protein kinase signaling from yeast to man. Trends Biochem Sci 27:514\u2013520. https:\/\/doi.org\/10.1016\/s0968-0004(02)02179-5","journal-title":"Trends Biochem Sci"},{"key":"750_CR46","doi-asserted-by":"publisher","first-page":"43702","DOI":"10.1038\/srep43702","volume":"7","author":"S Mateo-Lozano","year":"2017","unstructured":"Mateo-Lozano S, Bazzocco S, Rodrigues P, Mazzolini R, Andretta E, Dopeso H, Fern\u00e1ndez Y, Del Llano E, Bilic J, Su\u00e1rez-L\u00f3pez L, Macaya I (2017) Loss of the EPH receptor B6 contributes to colorectal cancer metastasis. Sci Rep 7:43702. https:\/\/doi.org\/10.1038\/srep43702","journal-title":"Sci Rep"},{"key":"750_CR47","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1002\/hep.27792","volume":"62","author":"PN Mimche","year":"2015","unstructured":"Mimche PN, Brady LM, Bray CF, Lee CM, Thapa M, King TP, Quicke K, McDermott CD, Mimche SM, Grakoui A, Morgan ET (2015) The receptor tyrosine kinase EphB2 promotes hepatic fibrosis in mice. Hepatol 62:900\u2013914. https:\/\/doi.org\/10.1002\/hep.27792","journal-title":"Hepatol"},{"key":"750_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-20926-9","volume":"8","author":"PN Mimche","year":"2018","unstructured":"Mimche PN, Lee CM, Mimche SM, Thapa M, Grakoui A, Henkemeyer M, Lamb TJ (2018) EphB2 receptor tyrosine kinase promotes hepatic fibrogenesis in mice via activation of hepatic stellate cells. Sci Rep 8:1\u201314. https:\/\/doi.org\/10.1038\/s41598-018-20926-9","journal-title":"Sci Rep"},{"key":"750_CR49","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/hep.26661","volume":"59","author":"CA Moylan","year":"2014","unstructured":"Moylan CA, Pang H, Dellinger A, Garrett ME, Guy CD, Murphy SK, Ashley-Loch AE, Choi SS, Michelotti GA, Hampton DD (2014) Hepatic gene expression profiles differentiate pre-symptomatic patients with mild versus severe nonalcoholic fatty liver disease. Hepatol 59:471\u2013482. https:\/\/doi.org\/10.1002\/hep.26661","journal-title":"Hepatol"},{"key":"750_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12860-017-0144-x","volume":"18","author":"M Mukai","year":"2017","unstructured":"Mukai M, Suruga N, Saeki N, Ogawa K (2017) EphA receptors and ephrin-A ligands are upregulated by monocytic differentiation\/maturation and promote cell adhesion and protrusion formation in HL60 monocytes. BMC Cell Biol 18:1\u201320. https:\/\/doi.org\/10.1186\/s12860-017-0144-x","journal-title":"BMC Cell Biol"},{"key":"750_CR51","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, Swain MG, Congly SE, Kaplan GG, Shaheen AA (2022) The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 7:851\u2013861. https:\/\/doi.org\/10.1016\/S2468-1253(22)00165-0","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"750_CR52","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S0168-8278(03)00498-7","volume":"39","author":"Y Sawai","year":"2003","unstructured":"Sawai Y, Tamura S, Fukui K, Ito N, Imanaka K, Saeki A, Sauda S, Kiso S, Matsuzawa Y (2003) Expression of ephrin-B1 in hepatocellular carcinoma: possible involvement in neovascularization. J Hepatol 39:991\u2013996. https:\/\/doi.org\/10.1016\/S0168-8278(03)00498-7","journal-title":"J Hepatol"},{"key":"750_CR53","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.cld.2015.10.001","volume":"20","author":"M Sayiner","year":"2016","unstructured":"Sayiner M, Koenig A, Henry L, Younossi ZM (2016) Epidemiology of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the United States and rest of the world. Clin Liver Dis 20:205\u2013214. https:\/\/doi.org\/10.1016\/j.cld.2015.10.001","journal-title":"Clin Liver Dis"},{"key":"750_CR54","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1053\/j.gastro.2008.04.010","volume":"135","author":"D Semela","year":"2008","unstructured":"Semela D, Das A, Langer D, Kang N, Leof E, Shah V (2008) Platelet-derived growth factor signaling through ephrin-b2 regulates hepatic vascular structure and function. Gastroenterol 135:671\u2013679. https:\/\/doi.org\/10.1053\/j.gastro.2008.04.010","journal-title":"Gastroenterol"},{"key":"750_CR55","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1002\/ijc.31979","volume":"144","author":"Y Sheng","year":"2019","unstructured":"Sheng Y, Wei J, Zhang Y, Gao X, Wang Z, Yang J, Yan S, Zhu Y, Zhang Z, Xu D, Wang C (2019) Mutated EPHA2 is a target for combating lymphatic metastasis in intrahepatic cholangiocarcinoma. Int J Can 144:2440\u20132452. https:\/\/doi.org\/10.1002\/ijc.31979","journal-title":"Int J Can"},{"key":"750_CR56","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bbamcr.2016.10.011","volume":"1864","author":"DR Singh","year":"2017","unstructured":"Singh DR, Ahmed F, Paul MD, Gedam M, Pasquale EB, Hristova K (2017) The SAM domain inhibits EphA2 interactions in the plasma membrane. Biochimica Et Biophysica Acta (BBA)-Mol Cell Res 1864:31\u201338. https:\/\/doi.org\/10.1016\/j.bbamcr.2016.10.011","journal-title":"Biochimica Et Biophysica Acta (BBA)-Mol Cell Res"},{"key":"750_CR57","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.biopha.2018.05.102","volume":"105","author":"A Srivastava","year":"2018","unstructured":"Srivastava A, Shukla V, Tiwari D, Gupta J, Kumar S, Kumar A (2018) Targeted therapy of chronic liver diseases with the inhibitors of angiogenesis. Biomed Pharmacother 105:256\u2013266. https:\/\/doi.org\/10.1016\/j.biopha.2018.05.102","journal-title":"Biomed Pharmacother"},{"key":"750_CR58","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"750_CR59","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/hpb.12359","volume":"17","author":"P Tabrizian","year":"2015","unstructured":"Tabrizian P, Jibara G, Hechtman JF, Franssen B, Labow DM, Schwartz ME, Thung SN, Sarpel U (2015) Outcomes following resection of intrahepatic cholangiocarcinoma. HPB 17:344\u2013351. https:\/\/doi.org\/10.1111\/hpb.12359","journal-title":"HPB"},{"key":"750_CR60","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cbpa.2018.06.011","volume":"225","author":"Y Tazaki","year":"2018","unstructured":"Tazaki Y, Sugitani K, Ogai K, Kobayashi I, Kawasaki H, Aoyama T, Suzuki N, Tabuchi Y, Hattori A, Kitamura KI (2018) RANKL, Ephrin\u2013Eph, and Wnt10b are key intercellular communication molecules regulating bone remodeling in autologous transplanted goldfish scales. Comp Biochem Physiol Part A Mol Integrative Physiol 225:46\u201358. https:\/\/doi.org\/10.1016\/j.cbpa.2018.06.011","journal-title":"Comp Biochem Physiol Part A Mol Integrative Physiol"},{"key":"750_CR61","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1080\/02699052.2019.1641622","volume":"33","author":"S Teng","year":"2019","unstructured":"Teng S, Palmieri A, Maita I, Zheng C, Das G, Park J, Zhou R, Alder J, Thakker-Varia S (2019) Inhibition of EphA\/Ephrin-A signaling using genetic and pharmacologic approaches improve recovery following traumatic brain injury in mice. Brain Inj 33:1385\u201341401. https:\/\/doi.org\/10.1080\/02699052.2019.1641622","journal-title":"Brain Inj"},{"issue":"3","key":"750_CR62","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/hep.23102","volume":"50","author":"Z Tong","year":"2009","unstructured":"Tong Z, Chen R, Alt DS, Kemper S, Perbal B, Brigstock DR (2009) Susceptibility to liver fibrosis in mice expressing a connective tissue growth factor transgene in hepatocytes. Hepatology 50(3):939\u2013947. https:\/\/doi.org\/10.1002\/hep.23102","journal-title":"Hepatology"},{"key":"750_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0041749","volume":"7","author":"TH Wang","year":"2012","unstructured":"Wang TH, Ng KF, Sen YT, Wang YL, Liang KH, Yeh CT, Chen TC (2012) Peritumoral small EphrinA5 isoform level predicts the postoperative survival in hepatocellular carcinoma. PLoS ONE 7:1\u201311. https:\/\/doi.org\/10.1371\/journal.pone.0041749","journal-title":"PLoS ONE"},{"key":"750_CR64","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.bbrc.2016.04.059","volume":"473","author":"Y Wang","year":"2016","unstructured":"Wang Y, Li Q, Zheng Y, Li G, Liu W (2016a) Systematic biochemical characterization of the SAM domains in Eph receptor family from Mus Musculus. Biochem Biophys Res Comm 473:1281\u20131287. https:\/\/doi.org\/10.1016\/j.bbrc.2016.04.059","journal-title":"Biochem Biophys Res Comm"},{"key":"750_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-016-0339-6","volume":"35","author":"Y Wang","year":"2016","unstructured":"Wang Y, Yu H, Shan Y, Tao C, Wu F, Yu Z, Guo P, Huang J, Li J, Zhu Q, Yu F (2016b) EphA1 activation promotes the homing of endothelial progenitor cells to hepatocellular carcinoma for tumor neovascularization through the SDF-1\/CXCR4 signaling pathway. J Exp Clin Cancer Res 35:1\u201315. https:\/\/doi.org\/10.1186\/s13046-016-0339-6","journal-title":"J Exp Clin Cancer Res"},{"key":"750_CR66","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/hep.29792","volume":"69","author":"X Wang","year":"2019","unstructured":"Wang X, Zhang M, Ping F, Liu H, Sun J, Wang Y, Shen A, Ding J, Geng M (2019) Identification and therapeutic intervention of coactivated anaplastic lymphoma kinase, fibroblast growth factor receptor 2, and ephrin type-A receptor 5 kinases in hepatocellular carcinoma. Hepatol 69:573\u2013586. https:\/\/doi.org\/10.1002\/hep.29792","journal-title":"Hepatol"},{"key":"750_CR67","doi-asserted-by":"publisher","first-page":"108765","DOI":"10.1016\/j.celrep.2021.108765","volume":"34","author":"H Wang","year":"2021","unstructured":"Wang H, Hou W, Perera A, Bettler C, Beach JR, Ding X, Li J, Denning MF, Dhanarajan A, Cotler SJ, Joyce C (2021) Targeting EphA2 suppresses hepatocellular carcinoma initiation and progression by dual inhibition of JAK1\/STAT3 and AKT signaling. Cell Rep 34:108765. https:\/\/doi.org\/10.1016\/j.celrep.2021.108765","journal-title":"Cell Rep"},{"key":"750_CR68","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2147\/CMAR.S232278","volume":"12","author":"Z Wu","year":"2020","unstructured":"Wu Z, Liu R, Xiong L, Miao X, Li D, Zou Q, Yuan Y, Yang Z (2020) Prognostic and clinicopathological significance of EphB3 and dysadherin expression in extrahepatic cholangiocarcinoma. Cancer Manag Res 12:221\u2013232. https:\/\/doi.org\/10.2147\/CMAR.S232278","journal-title":"Cancer Manag Res"},{"key":"750_CR69","doi-asserted-by":"publisher","first-page":"9653","DOI":"10.1126\/scitranslmed.adc9653","volume":"15","author":"Y Xiao","year":"2023","unstructured":"Xiao Y, Batmanov K, Hu W, Zhu K, Tom AY, Guan D, Jiang C, Cheng L, McCright SJ, Yang EC, Lanza MR, Liu Y, Hill DA, Lazar MA (2023) Hepatocytes demarcated by EphB2 contribute to the progression of nonalcoholic steatohepatitis. Sci Transl Med 15:9653. https:\/\/doi.org\/10.1126\/scitranslmed.adc9653","journal-title":"Sci Transl Med"},{"key":"750_CR70","doi-asserted-by":"publisher","first-page":"14634","DOI":"10.1073\/pnas.1311000110","volume":"110","author":"K Xu","year":"2013","unstructured":"Xu K, Tzvetkova-Robev D, Xu Y, Goldgur Y, Chan YP, Himanen JP, Nikolov DB (2013) Insights into Eph receptor tyrosine kinase activation from crystal structures of the EphA4 ectodomain and its complex with ephrin-A5. Proc Nat Acad Sci 110:14634\u201314639. https:\/\/doi.org\/10.1073\/pnas.1311000110","journal-title":"Proc Nat Acad Sci"},{"key":"750_CR71","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00262-009-0796-2","volume":"59","author":"S Yamaguchi","year":"2010","unstructured":"Yamaguchi S, Tatsumi T, Takehara T, Sasakawa A, Yamamoto M, Kohga K, Miyagi T, Kanto T, Hiramastu N, Akagi T, Akashi M, Hayashi N (2010) EphA2-derived peptide vaccine with amphiphilic poly(gamma-glutamic acid) nanoparticles elicits an anti-tumor effect against mouse liver tumor. Cancer Immunol Immunother 59:759\u2013767. https:\/\/doi.org\/10.1007\/s00262-009-0796-2","journal-title":"Cancer Immunol Immunother"},{"key":"750_CR72","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1111\/j.1872-034X.2009.00563.x","volume":"39","author":"P Yang","year":"2009","unstructured":"Yang P, Yuan W, He J, Wang J, Yu L, Jin X, Hu Y, Liao M, Chen Z, Zhang Y (2009) Overexpression of EphA2, MMP-9, and MVD-CD34 in hepatocellular carcinoma: implications for tumor progression and prognosis. Hepatol Res 39:1169\u20131177. https:\/\/doi.org\/10.1111\/j.1872-034X.2009.00563.x","journal-title":"Hepatol Res"},{"key":"750_CR73","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s12079-016-0346-6","volume":"10","author":"H Yeger","year":"2016","unstructured":"Yeger H, Perbal B (2016) CCN family of proteins: critical modulators of the tumor cell microenvironment. J Cell Commun Signal 10:229\u2013240. https:\/\/doi.org\/10.1007\/s12079-016-0346-6","journal-title":"J Cell Commun Signal"},{"key":"750_CR74","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/genes9020092","volume":"9","author":"L Yin","year":"2018","unstructured":"Yin L, Cai Z, Zhu B, Xu C (2018) Identification of key pathways and genes in the dynamic progression of HCC based on WGCNA. Genes (basel) 9:92. https:\/\/doi.org\/10.3390\/genes9020092","journal-title":"Genes (basel)"},{"key":"750_CR75","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1038\/s41467-018-05924-9","volume":"9","author":"J Yoon","year":"2018","unstructured":"Yoon J, Hwang YS, Lee M, Sun J, Cho HJ, Knapik L, Daar IO (2018) TBC1d24-ephrinB2 interaction regulates contact inhibition of locomotion in neural crest cell migration. Nat Comm 9:3491. https:\/\/doi.org\/10.1038\/s41467-018-05924-9","journal-title":"Nat Comm"},{"key":"750_CR76","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M (2016) Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatol 64:73\u201384. https:\/\/doi.org\/10.1002\/hep.28431","journal-title":"Hepatol"}],"container-title":["Journal of Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12079-023-00750-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12079-023-00750-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12079-023-00750-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T14:07:24Z","timestamp":1702649244000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12079-023-00750-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,27]]},"references-count":76,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["750"],"URL":"https:\/\/doi.org\/10.1007\/s12079-023-00750-1","relation":{},"ISSN":["1873-9601","1873-961X"],"issn-type":[{"value":"1873-9601","type":"print"},{"value":"1873-961X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,27]]},"assertion":[{"value":"14 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest<b>.<\/b>","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}